Fujian YEWPARK Biological Co., Ltd. was established in August 2008. The company is located in Mingxi County, Sanming City, Fujian Province, which enjoys the title of "China's Taxus Town", with a total investment of about 95 million yuan. The company has a complete plant extraction, purification and synthesis production line, as well as corresponding complete testing facilities and equipment. Relying on the parent company Fujian Sansan Pharmaceutical Co., Ltd. nearly 38,000 acres of artificially planted yew resources, the company annually extracts and purifies natural paclitaxel, 10-DABⅢ and its by-products up to thousands of kilograms, and maintains close cooperation with domestic famous pharmaceutical companies.
Fujian YEWPARK Biological Co., Ltd. is a company integrating R & D, production and sales. It is mainly engaged in the cultivation of Taxus chinensis var. Mairei, natural paclitaxel, 10-DABⅢ, 7-xylosid-10-deacetyl paclitaxel, cephalotaxine Extraction and purification, semi-synthetic paclitaxel, docetaxel, cabazitaxel and other anti-cancer drugs and intermediates research and development, production, and other high-tech companies extracting medicinal plants.